Skip to main content

Table 4 Comparison of foot function index scores by treatment group in 2018 and 2023

From: Analysis of foot function in terms of different pharmacological treatments in a cohort of patients with rheumatoid arthritis: a longitudinal study

FFI score

MTX (n = 42)

Bio (n = 115)

MTX + Bio (n = 33)

Miscellaneous (n = 16)

p-value

Total FFI (2018)

42.16 (24.1)

41.68 (28)

37.58 (24.9)

38.59 (22.2)

0.077

Total FFI (2023)

41.1 (22.7)

47.13 (26.1)

43.97 (23.3)

52.96 (20.3)

FFI Pain (2018)

45.76 (22.9)

41.48 (26.7)

40.09 (25.07)

39.19 (21.7)

0.011

FFI Pain (2023)

40.43 (20.8)

47.20 (26.7)

48.55 (20.1)

50.81 (19.9)

FFI Disability (2018)

42.79 (27.4)

43 (30.2)

37.67 (27.4)

42 (26.1)

0.301

FFI Disability (2023)

37 (25.8)

42.43 (27.2)

38.15 (27.9)

51.06 (21.8)

FFI Activity (2018)

8.43 (9.9)

11.9 (13.7)

8.67 (9.4)

7.56 (8.9)

0.077

FFI Activity (2023)

11.12 (11.8)

12.43 (10.9)

10.3 (9.8)

16.63 (12.4)

  1. FFI: Foot Function Index; MTX: Methotrexate; Bio: Biological